Profilin-9 Antibody

What is Profilin-1 and why is it important in research?

Profilin-1 is a ubiquitously expressed protein that controls actin polymerization in a concentration-dependent manner. It belongs to the Profilin family and plays a crucial role in cytoskeletal dynamics. Profilin-1 has gained significant research interest because mutations in the Profilin-1 gene (PFN1) have potential implications in neurodegenerative disease progression, particularly in amyotrophic lateral sclerosis (ALS) . Studies with PFN1 mutant mice carrying the G118V mutation have demonstrated motor defects consistent with ALS pathology, suggesting that detailed investigation of Profilin-1 could provide valuable insights into the pathogenic mechanisms of motor neuron diseases .

How are Profilin antibodies typically validated?

Profilin antibodies are validated through a standardized experimental protocol that compares antibody performance in knockout cell lines versus isogenic parental controls. This approach involves:

• Selecting cell lines with adequate Profilin expression levels (typically >2.5 log₂ TPM+1) based on transcriptomics databases

• Generating or obtaining knockout cell lines for the target protein

• Performing side-by-side comparisons of wild-type and knockout cells using the antibody in question

• Evaluating antibody performance in specific applications (Western blot, immunoprecipitation, immunofluorescence)

This rigorous validation ensures that positive signals are specific to the target protein and not a result of cross-reactivity with other cellular components.

What cell lines are commonly used for Profilin antibody validation?

Based on research data, HAP1 cells are frequently used for Profilin-1 antibody validation due to their suitable expression levels of PFN1. These cells are commercially available and have established knockout variants that facilitate comparative analysis .

This table summarizes the standard cell lines used in Profilin-1 antibody validation studies, providing researchers with reference information for designing their own validation experiments .

What are the main applications of Profilin antibodies in research?

Profilin antibodies are primarily used in three main applications:

• Western blot: To detect and quantify Profilin protein levels in cell or tissue lysates

• Immunoprecipitation: To isolate and study Profilin and its interaction partners

• Immunofluorescence: To visualize the subcellular localization and distribution of Profilin in cells or tissues

Each application requires specific antibody characteristics, and not all antibodies perform equally well across all applications. Researchers should select antibodies that have been validated for their specific intended application.

How can researchers design antibodies with customized specificity profiles for Profilin?

Creating antibodies with customized specificity profiles for Profilin involves a combination of experimental selection and computational modeling. Recent advances demonstrate that:

• Initial antibody libraries can be generated using phage display with systematic variation in the complementarity-determining regions (CDRs)

• High-throughput sequencing can be used to analyze the resulting antibody variants

• Biophysics-informed computational models can identify distinct binding modes associated with particular ligands

• These models can then guide the design of novel antibodies with either specific high affinity for a particular target or cross-specificity for multiple targets

The process involves optimizing energy functions associated with each binding mode, minimizing those for desired interactions while maximizing those for undesired interactions when specificity is the goal . This approach enables researchers to go beyond the limitations of experimental selection alone and design antibodies with precisely tailored binding properties.

What are the challenges in distinguishing between different Profilin isoforms using antibodies?

Distinguishing between different Profilin isoforms presents significant challenges due to their structural similarities. Advanced strategies to address this include:

• Epitope mapping to identify unique regions specific to each isoform

• Computational analysis of binding modes to disentangle interactions with chemically similar ligands

• Negative selection strategies to eliminate cross-reactive antibodies

• Custom design of antibodies using biophysics-informed modeling to achieve isoform specificity

Researchers must carefully validate antibody specificity using knockout controls for each isoform to ensure reliable discrimination between closely related Profilin family members.

How do different antibody detection methods compare in terms of sensitivity and specificity for Profilin research?

Different antibody detection methods exhibit varying sensitivity and specificity profiles when used for Profilin research:

• Western blot: Provides good specificity when validated against knockout controls but may have limited sensitivity for detecting low abundance Profilin variants

• ELISA: Offers higher sensitivity but may show cross-reactivity between isoforms if not carefully validated

• Immunofluorescence: Provides valuable spatial information but requires rigorous controls to distinguish specific from non-specific signals

• Mass spectrometry-based immunoprecipitation: Offers the highest specificity for identifying Profilin variants and interaction partners

The choice of method should be guided by the specific research question, with consideration for the trade-offs between sensitivity, specificity, and the type of information required.

What are the implications of Profilin mutations in neurodegenerative diseases and how can antibodies help study these mechanisms?

Profilin-1 mutations have been implicated in neurodegenerative diseases, particularly ALS. Well-characterized antibodies can help elucidate the underlying mechanisms by:

• Detecting altered protein levels or subcellular localization of mutant Profilin

• Identifying changes in Profilin-actin interactions resulting from disease-associated mutations

• Studying potential aggregation or misfolding of mutant Profilin proteins

• Investigating changes in Profilin's interaction network in disease states

Mouse models carrying the G118V mutation in Profilin-1 show motor defects consistent with ALS pathology, making them valuable tools for studying disease mechanisms when combined with specific antibodies .

What protocols should be followed for optimal Western blot detection of Profilin?

For optimal Western blot detection of Profilin, researchers should follow these methodological guidelines:

• Sample preparation:

  • Collect cells in RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS)

  • Supplement with 1× protease inhibitor cocktail mix

  • Sonicate briefly and incubate for 30 min on ice

  • Centrifuge at ~110,000× g for 15 min at 4°C

• SDS-PAGE and transfer:

  • Use precast midi 10% Bis-Tris polyacrylamide gels

  • Run with MES SDS buffer

  • Load in LDS sample buffer with 1× sample reducing agent

  • Transfer to nitrocellulose membranes

• Antibody incubation:

  • Block with 5% milk for 1 hr

  • Incubate primary antibodies overnight at 4°C in 5% BSA in TBST

  • Wash three times with TBST

  • Incubate with peroxidase-conjugated secondary antibody

Including both wild-type and knockout samples on the same blot provides crucial validation of antibody specificity.

What are the best practices for immunoprecipitation using Profilin antibodies?

Effective immunoprecipitation of Profilin requires careful attention to several methodological details:

• Antibody-bead conjugate preparation:

  • Add 2 μg or 20 μL of antibody to 500 μL of IP Lysis Buffer

  • Add 30 μL of Dynabeads protein A (for rabbit antibodies) or protein G (for mouse antibodies)

  • Rock for ~1 hr at 4°C

  • Wash twice to remove unbound antibodies

• Cell lysate preparation:

  • Lyse cells in appropriate buffer with protease inhibitors

  • Clear lysates by centrifugation

  • Pre-clear with beads alone to reduce non-specific binding

• Immunoprecipitation procedure:

  • Incubate antibody-bead conjugates with pre-cleared lysates

  • Wash thoroughly to remove non-specific interactions

  • Elute bound proteins for downstream analysis

Validation should include comparison of input, unbound, and immunoprecipitated fractions from both wild-type and knockout samples.

How should researchers approach immunofluorescence staining for Profilin?

For reliable immunofluorescence staining of Profilin, researchers should follow this methodology:

• Sample preparation:

  • Fix cells in 4% paraformaldehyde in PBS for 15 min at room temperature

  • Wash three times with PBS

  • Permeabilize in PBS with 0.1% Triton X-100 for 10 min

  • Block with PBS containing 5% BSA, 5% goat serum, and 0.01% Triton X-100 for 30 min

• Antibody staining:

  • Incubate with primary Profilin antibodies in IF buffer (PBS, 5% BSA, 0.01% Triton X-100) overnight at 4°C

  • Wash three times for 10 min with IF buffer

  • Incubate with Alexa Fluor-conjugated secondary antibodies (1.0 μg/mL) for 1 hr

  • Counterstain nuclei with DAPI

• Validation approach:

  • Use a mosaic strategy by plating wild-type and knockout cells together

  • Image both cell types in the same field of view to reduce staining, imaging, and analysis bias

This approach ensures reliable detection while controlling for artifacts and non-specific binding.

How can computational approaches enhance antibody design for Profilin research?

Computational approaches offer powerful tools for designing antibodies with custom specificity profiles for Profilin research:

• Data acquisition:

  • Perform phage display experiments with antibody libraries

  • Conduct high-throughput sequencing of selected antibodies

• Model building:

  • Develop biophysics-informed computational models

  • Identify distinct binding modes associated with particular ligands

  • Train the model on experimental data

• Antibody design:

  • For specific antibodies: minimize energy functions for the desired target while maximizing them for undesired targets

  • For cross-specific antibodies: jointly minimize energy functions for all desired targets

  • Generate and experimentally validate predicted sequences

This integrated approach allows researchers to go beyond the limitations of selection alone and design antibodies with precise binding properties tailored to their research needs.